Invesco NASDAQ Biotechnology ETF
IBBQ
9 hedge funds and large institutions have $44.8M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
0.15% less ownership
Funds ownership: 0.53% → 0.38% (-0.15%)
29% less capital invested
Capital invested by funds: $63.5M → $44.8M (-$18.7M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$4.94M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$527K |
| 3 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$494K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$10.4M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.33M |
| 3 |
JP Morgan Chase
New York
|
-$4.25M |
| 4 |
Morgan Stanley
New York
|
-$1.32M |
IBBQ Hedge Fund Activity: Q3 2021 in Review
9 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2021, worth a combined $44.8M — down 29% from $63.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IBBQ positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Mirae Asset Global Investments, adding an estimated $4.94M. The largest seller was Credit Suisse, exiting entirely with an estimated $10.4M sold.
- 9 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2021, up from 7 in Q2 2021.
- Funds reported $44.8M of Invesco NASDAQ Biotechnology ETF stock for Q3 2021, down 29% quarter-over-quarter.
- 3 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2021 and 1 closed out, a net change of +2 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2021 was Mirae Asset Global Investments, an estimated $4.94M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2021 was Credit Suisse, an estimated $10.4M sold.
Based on aggregated 13F filings for Q3 2021.